कृपया अन्य खोज का प्रयास करें
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company’s lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Hans T. Schambye | 57 | 2020 | Co-Founder, President, CEO & Director |
Carl S. Goldfischer | 64 | 2020 | Independent Chairman of the Board |
Chau Quang Khuong | 48 | 2015 | Independent Director |
Jayson Donald Alexander Dallas | 56 | 2020 | Independent Director |
Anne Prener | 66 | 2021 | Independent Director |
Mark Thursz | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Stephen A. Harrison | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Aaron Gerds | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Claire Harrison | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
William L. Redmond | - | - | Member of Clinical Advisory Board – Oncology |
Raajit Rampal | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Adam Mead | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Amit D. Munshi | 56 | 2020 | Independent Director |
Jonathan Fallowfield | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
Roy Steven Herbst | 61 | - | Member of Clinical Advisory Board – Oncology |
Søren Møller | 57 | 2020 | Independent Director |
David Shapiro | 70 | 2020 | Independent Director |
John Mascarenhas | - | - | Member of the Clinical Advisory Board - Myelofibrosis |
Alexander Maximiliaan Marie Eggermont | - | - | Member of Clinical Advisory Board – Oncology |
Michael Charlton | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
Federico Cappuzzo | - | - | Member of Clinical Advisory Board – Oncology |
Massimo Pinzani | - | - | Member of Clinical Advisory Board – Liver Cirrhosis |
Jasmohan Bajaj | - | - | Member of Clinical Advisory Board – Liver cirrhosis |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है